![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
Pronóstico del mercado de subcontratación de asuntos regulatorios de atención médica de Asia Pacífico hasta 2028: impacto de COVID-19 y análisis regional por tipo de servicio (desarrollo de estrategias científicas y regulatorias, redacción médica y científica, eCTD y presentaciones electrónicas, servicios de gestión de datos, servicios de gestión del ciclo de vida, farmacovigilancia, Servicios de fabricación y controles químicos (CMC), etiquetado reglamentario y servicios de ilustraciones reglamentarias) y usuario final (empresas farmacéuticas, empresas de biotecnología y empresas de dispositivos médicos).
Introducción al mercado
Asia Pacífico está formada por cinco países principales: China, Japón, India, Australia y Corea del Sur. El mercado también se evalúa para el resto de países de Asia Pacífico. El mercado está impulsado por factores como costos relativamente más bajos de subcontratación, fuerza laboral calificada con experiencia técnica y expansión de las empresas de atención médica en países como India y China. Además, se espera que un número cada vez mayor de ensayos clínicos y un número cada vez mayor de empresas que intentan ingresar a mercados en economías emergentes como India, el Sudeste Asiático y China contribuyan al crecimiento del mercado para la subcontratación de asuntos regulatorios de atención médica durante el período de pronóstico. El mercado farmacéutico japonés está creciendo exponencialmente. Para abordar las necesidades de la creciente población que envejece en Japón, el gobierno se está centrando en flexibilizar las políticas regulatorias y así acelerar el desarrollo y la aprobación de nuevos medicamentos en el mercado. Se espera que esto atraiga a las compañías farmacéuticas globales ya existentes y a los nuevos participantes a establecer su mercado en Japón. Se espera que esto aumente la demanda de diversos servicios de subcontratación regulatoria que requieren desde el desarrollo del Tipo de Servicio hasta la etapa de comercialización del Tipo de Servicio. Para reducir el costo y agilizar el cronograma del tipo de servicio, las empresas se están centrando principalmente en subcontratar las actividades regulatorias y de farmacovigilancia a las industrias. Se espera que esto impulse el crecimiento del mercado de subcontratación de asuntos regulatorios de atención médica en este país. Los avances en terapias especializadas, medicamentos huérfanos y medicamentos personalizados son el factor principal que impulsa el crecimiento del mercado de subcontratación de asuntos regulatorios de atención médica de APAC.
Con un mercado de suministro favorable, la fuerte presencia de CRO globales y regionales con experiencia local: las compañías farmacéuticas perciben a Asia-Pacífico como un mercado atractivo para realizar ensayos clínicos. Sin embargo, la pandemia de COVID-19 ha planteado desafíos sin precedentes en todo el mundo. El impacto de la COVID-19 en los asuntos clínicos y regulatorios, las cadenas de fabricación y suministro y la participación de las partes interesadas ha ralentizado el ritmo de la industria farmacéutica en constante crecimiento. Australia ha sido apreciada a nivel mundial por sus medidas para gestionar la propagación de la COVID-19 con estrictos sistemas de cuarentena y rastreo avanzado de contactos; sin embargo, la participación de pacientes/voluntarios en ensayos clínicos disminuyó en algunos sitios ya que los participantes no estaban dispuestos a asistir a clínicas u hospitales por temor a la infección. Así, la situación de pandemia ha provocado la interrupción de ensayos clínicos, retrasos en la aprobación de productos e interrupciones en las cadenas de suministro. La pandemia ha obligado a las empresas farmacéuticas y a las agencias reguladoras a adoptar estrategias innovadoras para mitigar los desafíos observados en diversos dominios funcionales. El impacto de COVID-19 ha provocado retrasos en la inspección in situ debido a prohibiciones de viaje y retrasos en la aprobación de varios productos. Esto ha provocado la subcontratación de ~65% de las actividades farmacéuticas a CRO, y se espera que la cifra alcance el 75% en el futuro. Además de esto, la demanda de productos farmacéuticos innovadores ha presionado a las empresas farmacéuticas para que aumenten su gasto en I+D para ofrecer nuevos productos, manteniendo inalterados los costos operativos. Estas condiciones también han desencadenado inversiones en plataformas digitales, que permiten a los médicos controlar a los pacientes de forma remota de manera eficiente. Todos estos factores tendrán un impacto en los negocios de subcontratación de asuntos regulatorios de atención médica en Asia Pacífico.
Descripción general y dinámica del mercado
Se espera que el mercado de subcontratación de asuntos regulatorios de atención médica en APAC crezca de 1.203,97 millones de dólares en 2021 a 2.586,87 millones de dólares en 2028; se estima que crecerá a una tasa compuesta anual del 11,5% de 2021 a 2028. La industria de asuntos regulatorios de atención médica está muy fragmentada con varios cientos de proveedores pequeños y medianos de servicios limitados y una pequeña cantidad de CRO multinacionales grandes y de servicio completo. . Las CRO pequeñas enfrentan algunas barreras para ingresar al mercado de subcontratación de asuntos regulatorios de atención médica, mientras que las CRO de servicio completo con presencia regional necesitan construir la infraestructura necesaria con la capacidad de administrar simultáneamente múltiples servicios regulatorios complejos en numerosos países; estos últimos también necesitan construir las relaciones necesarias con socios estratégicos, desarrollando terapias relevantes y desarrollando experiencia para satisfacer las necesidades de sus clientes. La consolidación en la industria de asuntos regulatorios es una tendencia emergente que ayuda a los principales actores a fortalecer sus ofertas de servicios y obtener la mayor participación en el mercado. Sin embargo, esto ha llevado a la generación de un puñado de CRO más grandes con amplio alcance, amplia experiencia terapéutica y de desarrollo, enorme capital y recursos técnicos, lo que les permite gestionar los exigentes programas de desarrollo de fármacos de las empresas farmacéuticas y biofarmacéuticas.
Segmentos de mercado clave
El mercado de subcontratación de asuntos regulatorios de atención médica de APAC ha se ha segmentado según el tipo de servicio, el usuario final y el país. Según el tipo de servicio, el mercado de subcontratación de asuntos regulatorios de atención médica de APAC se segmenta en servicios médicos y de salud. redacción científica, farmacovigilancia, servicios de gestión de datos, servicios de gestión del ciclo de vida, eCTD y presentaciones electrónicas, desarrollo de estrategias científicas y regulatorias, servicios de fabricación y controles químicos (CMC), etiquetado regulatorio y servicios de arte regulatorio. El médico y El segmento de redacción científica dominó el mercado en 2020 y se espera que el segmento de farmacovigilancia sea el de más rápido crecimiento durante el período de pronóstico. Según el usuario final, el mercado se segmenta en empresas farmacéuticas, empresas de biotecnología y empresas de dispositivos médicos. El segmento de empresas farmacéuticas dominó el mercado en 2020 y se espera que sea el de más rápido crecimiento durante el período previsto. Asimismo, las empresas de dispositivos médicos segmentadas se clasifican en materiales y materiales para dispositivos médicos. biomateriales, dispositivos médicos, biomarcadores y diagnóstico in vitro (IVD), software de dispositivos médicos (SaMD), electromecánica de dispositivos médicos, dispositivos médicos basados en sustancias y dispositivos médicos de productos combinados.
< span>Principales fuentes y empresas enumeradas
Algunas de las principales fuentes primarias y secundarias mencionadas para preparar este informe sobre atención médica El mercado de subcontratación de asuntos regulatorios en APAC son los sitios web de las empresas, informes anuales, informes financieros, documentos del gobierno nacional y bases de datos estadísticas, entre otros. Las principales empresas que figuran en el informe son Arriello Ireland Ltd., Azierta Contract Science Support Consulting, IQVIA Inc., PAREXEL INTERNATIONAL CORPORATION, PHARMALEX GMBH, ProductLife Group, ProPharma Group y Voisin Consulting Life Sciences (VCLS), entre otras.
Informe de razones para comprar
- Comprender el panorama del mercado de subcontratación de asuntos regulatorios de atención médica de APAC e identificar los segmentos de mercado que tienen más probabilidades de garantizar un fuerte retorno
- Manténgase a la vanguardia al comprender el panorama competitivo en constante cambio para el mercado de subcontratación de asuntos regulatorios de atención médica de APAC
- Planifique de manera eficiente fusiones y adquisiciones y acuerdos de asociación en el sector regulatorio de atención médica de APAC. mercado de subcontratación de asuntos regulatorios de atención médica al identificar los segmentos de mercado con las ventas probables más prometedoras
- Ayuda a tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos de subcontratación de asuntos regulatorios de atención médica de APAC mercado
- Obtenga un pronóstico de ingresos de mercado para varios segmentos de 2021 a 2028 en la región APAC.
Segmentación del mercado de subcontratación de asuntos regulatorios de atención médica de APAC
Atención médica de APAC Mercado de subcontratación de asuntos regulatorios: por tipo de servicio
- Médico y ; Escritura científica
- Farmacovigilancia
- Servicios de gestión de datos
- Ciclo de vida Servicios de gestión
- eCTD y e-Submissions
- Desarrollo de estrategias científicas y regulatorias
- Servicios de controles y fabricación de productos químicos (CMC)
- Etiquetado reglamentario
- Servicios de material gráfico reglamentario
Mercado de subcontratación de asuntos regulatorios de atención médica de APAC: por usuario final
- Empresas farmacéuticas
- Empresas de biotecnología
- Empresas de dispositivos médicos
- Materiales y materiales para dispositivos médicos Biomateriales
- Biomarcadores de dispositivos médicos y diagnóstico in vitro (IVD)
- Software de dispositivos médicos (SaMD)
- Electromecánica de dispositivos médicos
- Dispositivo médico basado en sustancias
- Dispositivo médico de producto combinado
Mercado de subcontratación de asuntos regulatorios de atención médica de APAC, por país
- Japón
- China
- India
- Corea del Sur
- Australia
- Resto de APAC
Mercado de subcontratación de asuntos regulatorios de atención médica de APAC -Perfiles de empresas
- Arriello Ireland Ltd.
- Azierta Contract Science Support Consulting
- IQVIA Inc.
- PAREXEL CORPORACIÓN INTERNACIONAL
- PHARMALEX GMBH
- Grupo ProductLife
- Grupo ProPharma
- Voisin Consulting Life Sciences (VCLS) >ul>
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 APAC Healthcare Regulatory Affairs Outsourcing Market – By Service Type
1.3.2 APAC Healthcare Regulatory Affairs Outsourcing Market – By End User
1.3.3 APAC Healthcare Regulatory Affairs Outsourcing Market – By Country
2. APAC Healthcare Regulatory Affairs Outsourcing Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. APAC Healthcare Regulatory Affairs Outsourcing Market – Market Landscape
4.1 Overview
4.1.1 Asia Pacific– PEST Analysis
4.2 Expert Opinions
5. APAC Healthcare Regulatory Affairs Outsourcing Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Regulatory Pressure on Healthcare Companies
5.1.2 Escalating Demand for Speedy Approval of New Products
5.2 Market Restraints
5.2.1 Dearth of Skilled Professionals
5.3 Market Opportunities
5.3.1 Advancements in Specialty Therapies, Orphan Drugs, and Personalized Medicines
5.4 Future Trends
5.4.1 Surging Market Consolidation Activities
5.5 Impact Analysis
6. Healthcare Regulatory Affairs Outsourcing Market – APAC Analysis
6.1 APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Forecast and Analysis
7. Healthcare Regulatory Affairs Outsourcing Market Analysis – By Service Type
7.1 Overview
7.2 Healthcare Regulatory Affairs Outsourcing Market, by Service Type (2021 and 2028)
7.3 Regulatory and Scientific Strategy Development
7.3.1 Overview
7.3.2 Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Medical and Scientific Writing
7.4.1 Overview
7.4.2 Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.5 eCTD and E-Submissions
7.5.1 Overview
7.5.2 eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Data Management Services
7.6.1 Overview
7.6.2 Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Life Cycle Management Services
7.7.1 Overview
7.7.2 Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Pharmacovigilance
7.8.1 Overview
7.8.2 Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Chemistry Manufacturing and Controls (CMC) Services
7.9.1 Overview
7.9.2 Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Regulatory Labelling
7.10.1 Overview
7.10.2 Regulatory Labelling : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
7.11 Regulatory Artwork Services
7.11.1 Overview
7.11.2 Regulatory Artwork Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8. APAC Healthcare Regulatory Affairs Outsourcing Market Analysis – By End User
8.1 Overview
8.2 Healthcare Regulatory Affairs Outsourcing Market, by End-User (2020 and 2028)
8.3 Pharmaceutical Companies
8.3.1 Overview
8.3.2 Pharmaceutical Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Biotechnology Companies
8.4.1 Overview
8.4.2 Biotechnology Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Medical Device Companies
8.5.1 Overview
8.5.2 Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
8.5.2.1 Medical Device Software (SaMD) Market
8.5.2.1.1 Overview
8.5.2.1.2 Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.2 Medical Device Materials & Biomaterials Market
8.5.2.2.1 Overview
8.5.2.2.2 Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.3 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market
8.5.2.3.1 Overview
8.5.2.3.2 Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.4 Medical Device Electro mechanics Market
8.5.2.4.1 Overview
8.5.2.4.2 Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.5 Medical Device Substance Based Market
8.5.2.5.1 Overview
8.5.2.5.2 Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
8.5.2.6 Medical Device of Combination Product (DDC) Market
8.5.2.6.1 Overview
8.5.2.6.2 Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market –Revenue and Forecast to 2028 (US$ Million)
9. APAC Healthcare Regulatory Affairs Outsourcing Market – Country Analysis
9.1 Overview
9.1.1 Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Country, 2021 & 2028 (%)
9.1.1.1 China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.1 China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.1.2 China: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.1.3 China: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.1.3.1 China: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.2 Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.1 Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.2.2 Japan: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.2.3 Japan: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.2.3.1 Japan: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.3 India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.1 India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.3.2 India: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.3.3 India: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.3.3.1 India: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.4 Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.1 Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.4.2 Australia: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.4.3 Australia: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.4.3.1 Australia: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.5 South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.1 South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.5.2 South Korea: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.5.3 South Korea: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.5.3.1 South Korea: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
9.1.1.6 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.1 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
9.1.1.6.2 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, By Service Type, 2019–2028 (USD Million)
9.1.1.6.3 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by End User, 2019–2028 (USD Million)
9.1.1.6.3.1 Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on APAC Healthcare Regulatory Affairs Outsourcing Market
10.1 Overview
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12. Company Profiles
12.1 ProPharma Group
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Arriello Ireland Ltd.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 PAREXEL INTERNATIONAL CORPORATION
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 IQVIA Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PHARMALEX GMBH
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 ProductLife Group
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Voisin Consulting Life Sciences (VCLS)
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Azierta Contract Science Support Consulting
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue and Forecast to 2028 (US$ Million)
Table 2. China: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 3. China: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 4. China: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 5. Japan: Healthcare Regulatory Affairs Outsourcing Market, By Service Type– Revenue and Forecast to 2028 (USD Million)
Table 6. Japan: Healthcare Regulatory Affairs Outsourcing Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Japan: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies – Revenue and Forecast to 2028 (USD Million)
Table 8. India: Healthcare Regulatory Affairs Outsourcing Market, By Service Type– Revenue and Forecast to 2028 (USD Million)
Table 9. India: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 10. India: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 11. Australia: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Australia: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Australia: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 14. South Korea: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 15. South Korea: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 16. South Korea: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, By Service Type – Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Medical Devices Companies– Revenue and Forecast to 2028 (USD Million)
Table 20. Organic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 21. Inorganic Developments in the Healthcare Regulatory Affairs Outsourcing Market
Table 22. Glossary of Terms, APAC Healthcare Regulatory Affairs Outsourcing Market
LIST OF FIGURES
Figure 1. APAC Healthcare Regulatory Affairs Outsourcing Market Segmentation
Figure 2. APAC Healthcare Regulatory Affairs Outsourcing Market Segmentation, By Country
Figure 3. APAC Healthcare Regulatory Affairs Outsourcing Market Overview
Figure 4. Medical & Scientific Writing Segment Held the Largest Share of the Service Type Segment in APAC Healthcare Regulatory Affairs Outsourcing Market
Figure 5. India to Show Significant Growth During Forecast Period
Figure 6. Asia pacific PEST Analysis
Figure 7. APAC Healthcare Regulatory Affairs Outsourcing Market Impact Analysis of Driver and Restraints
Figure 8. APAC Healthcare Regulatory Affairs Outsourcing Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by Service Type (2020 and 2028)
Figure 10. APAC Regulatory and Scientific Strategy Development: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. APAC Medical and Scientific Writing: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. APAC eCTD and E-Submissions: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. APAC Data Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. APAC Life Cycle Management Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. APAC Pharmacovigilance : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. APAC Chemistry Manufacturing & Controls ((CMC) Services: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. APAC Regulatory Labelling: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. APAC Regulatory Artwork Services : Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. APAC Healthcare Regulatory Affairs Outsourcing Market Revenue Share, by End-User (2020 and 2028)
Figure 20. APAC Pharmaceutical Companies : Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. APAC Biotechnology Companies: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. APAC Medical Device Companies: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. APAC Medical Device Software (SaMD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. APAC Medical Device Materials & Biomaterials Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. APAC Medical Device Biomarkers and In-vitro Diagnostics (IVD) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. APAC Medical Device Electro mechanics Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. APAC Medical Device Substance Based Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. APAC Medical Device of Combination Product (DDC) Market: Healthcare Regulatory affairs outsourcing Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Key Country – Revenue (2021) (USD Million)
Figure 30. Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market, by Country, 2021 & 2028 (%)
Figure 31. China: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Japan: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. India: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Australia: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 35. South Korea: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 36. Rest of Asia Pacific: Healthcare Regulatory Affairs Outsourcing Market – Revenue and Forecast to 2028 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Arriello Ireland Ltd.
- Azierta Contract Science Support Consulting
- IQVIA Inc.
- PAREXEL INTERNATIONAL CORPORATION
- PHARMALEX GMBH
- ProductLife Group
- ProPharma Group
- Voisin Consulting Life Sciences (VCLS)
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the APAC Healthcare Regulatory Affairs Outsourcing market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the APAC Healthcare Regulatory Affairs Outsourcing market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the Healthcare Regulatory Affairs Outsourcing market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution